AZB & Partners advised PAG Asia Capital HK Limited, while Desai & Diwanji advised Anjan Drug.
Gamot, an investment platform formed by private equity (PE) firm PAG along with PE funds CX Partners and Samara Capital, completed the acquisition of a controlling stake in Anjan Drug.
Anjan Drug Private Limited manufactures pharmaceutical ingredients. The Company supplies valproic acid, sodium valproate, divalproex sodium, magnesium valporate, and gabapentin products.
The AZB & Partners team was led by partners Ashwath Rau (Picture) and Atreya Bhattacharya, senior associate Raina Upadhyay.
The Desai & Diwanji team was led by partner Siddarth Modywith, senior associates Rahul Deodhar and Prerana Chaudhari.
Involved fees earner: Atreya Bhattacharya – Azb & partners; Ashwath Rau – Azb & partners; Raina Upadhyay – Azb & partners; Prerana Chaudhari – Desai & Diwanji; Rahul Deodhar – Desai & Diwanji; Siddharth Mody – Desai & Diwanji;